Our Partners











General Criteria

Call for Research Proposals

The Canadian Hemophilia Society, in collaboration with Pfizer Canada (formerly Wyeth), has established the Care Until Cure research program to support clinical research, including outcome evaluation, to improve the quality of life of persons with hemophilia and other inherited bleeding disorders.

Eligibility

Applicants must be Canadian citizens or landed immigrants and affiliated with a Canadian university or health-related organization. Grants will be made available for clinical research, including outcome evaluation, in fields relevant to improving the quality of life of:

  • hemophiliacs
  • persons with von Willebrand disease or other inherited bleeding disorders
  • persons with related conditions such as HIV or hepatitis C
  • carriers of an inherited bleeding disorder.

    For the 2011-2012 edition of the program, specific areas of interest have been identified and investigators, where possible, are encouraged to submit proposals within these areas. While the grants review committee will continue to allocate funding to the strongest and most relevant projects, preference will be given to those projects which correspond to the areas of interest listed below.

    2011-2012 AREAS OF INTEREST:
    Hemophilia B:
    1. Epidemiology / burden of disease / outcome research
    2. Routine prophylaxis and preventative treatment
    3. Surgical prophylaxis, dosing
    4. Recovery experience (hemophilia B)
    5. Joint outcomes and optimizing therapy
    Transition and clinical issues:
    1. Treatment adherence to prescribed regiments
    2. Management of adolescent hemophilia patients
    3. Management of aging hemophilia population
    Clinical monitoring of hemophilia treatment
    Product switching experience:
    1. Rationale for switching products
    2. Inhibitor development and safety associated with switches
    Inhibitors
    Factor VIII molecule
    Antifibrinolytics


Location of Tenure

The research will be conducted in Canada by Canadian researchers affiliated with Canadian universities and not-for-profit health-related organizations.

Grant amount / Duration of Support

Individual grants will be awarded for one to two years with a maximum of $75,000.00 per year. Second year funding can be awarded based on the evaluation of a first year progress report. Grant period will begin on April 1, 2012.

Funds will be disbursed in two payments.

General Conditions and Application Form

Applications must be completed and submitted electronically to the Canadian Hemophilia Society and one (1) original paper copy, including signatures, must be sent to the National Office of the Canadian Hemophilia Society:

400-1255 University Street, Montreal, QC H3B 3B6

Please click on the following links for General Conditions and Application Form.


Deadlines

Please note that the CHS will not be accepting new applications at this time for the year 2012-13. The funds have been earmarked for second year projects which began in 2011. Should new funds become available for 2012, a call for new applications will be issued.

Evaluation

Applications will be reviewed and evaluated by an independent peer review committee composed of Canadian medical and scientific healthcare professionals. This committee will make final decisions on the awarding of the grants.